Integrated iodine biokinetic models for pregnancy and lactation based on the ICRP reference adult model
Tae-Eun Kwon1, Vladimir Drozdovitch1, Jim Z Mai1
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States of America.
Abstract:
Exposure to radioactive iodine (radioiodine) during pregnancy and lactation poses unique risks to both mothers and their offspring due to altered iodine metabolism and heightened radiosensitivity. Existing biokinetic models, such as those developed by Berkovski, have provided a foundation for understanding iodine kinetics in these physiological states but lack integration with the latest International Commission on Radiological Protection (ICRP) reference model for non-pregnant adults. In this study, we developed integrated biokinetic models for pregnancy and lactation that are structurally consistent with the ICRP Publication 137 adult iodine model. Our models account for physiological changes in renal clearance, thyroid hormone production, and iodide uptake during pregnancy, and incorporate fetal compartments for transplacental iodine transfer. The lactation model introduces a breast milk compartment to reflect iodine excretion via nursing, using observed transfer factors and milk production rates. Model predictions were validated against clinical data and compared with outputs from the Berkovski model. The proposed models demonstrated improved agreement with observed iodine concentrations in maternal blood, placenta, amniotic fluid, and breast milk, offering more accurate predictions of iodine biokinetics within the maternal body and its lactational excretion. This integrated framework allows for consistent dose estimation across non-pregnant, pregnant, and lactating states, providing a valuable tool for internal dose assessment and radiation risk analysis in vulnerable populations. Future applications include the calculation of absorbed dose coefficients for maternal and fetal organs following radioiodine exposure.
More Related Videos
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
08:08Determination of the Transport Rate of Xenobiotics and Nanomaterials Across the Placenta using the ex vivo Human Placental Perfusion Model
Published on: June 18, 2013
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Physiological Models
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological Pharmacokinetic Models: Assumption with Protein Binding
One-Compartment Open Model for IV Bolus Administration: General Considerations
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
